Eli Lilly (NY:LLY)

Stock Market Today, Feb. 23: Nvidia Earnings Loom as Tariff Concerns Drive Dow 800 Points Lower ↗

Topics Stocks

February 23, 2026

AI jitters, tariff shock, and looming Nvidia results have investors fleeing growth for perceived safety, today, Feb. 23, 2026.

It's worth sticking with the stock through the hard times.

Topics Artificial Intelligence Government Stocks

1 Reason I'd Buy Veeva Systems Stock and Never Sell ↗

February 23, 2026

Novo Nordisk stock tanks as CagriSema appears inferior to Eli Lilly’s competing weight-loss drug in a late-stage trial. But NVO shares are still worth buying at current levels.

Novo Nordisk Stock Is Deeply Oversold on Weight Loss Drug Fail. Should You Buy the Dip?

February 23, 2026

Via Barchart.com

Eli Lilly (LLY) Stock Is Up, What You Need To Know

February 23, 2026

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.8% in the afternoon session after a major competitor, Novo Nordisk, announced that its experimental obesity drug failed to show it...

WASHINGTON D.C. — In a dramatic shift of the global economic landscape, the United States is currently witnessing a massive "repatriation" of industrial capacity, commonly referred to as the US...

Topics Artificial Intelligence

The Great Reshoring: US Manufacturing Renaissance Hits High Gear Amid Tariff Volatility

February 23, 2026

Novo Nordisk Shares Tumble 15.1% After CagriSema Fails to Topple Eli Lilly in Head-to-Head Trial

Topics Economy Government World Trade

February 23, 2026

The undisputed reign of Novo Nordisk in the weight-loss drug sector faced its most severe challenge to date on February 23, 2026, as the company’s US-traded shares (NYSE: NVO) plummeted 15.1% in a...

A potential competitive threat to Viking's phase 3 weight-loss drug VK2735 was just dealt a major blow.

Why Viking Therapeutics Stock Is Up More Than 9% Today ↗

February 23, 2026

Hedge Funds' Mag 7, Eli Lilly Buying Spree Sparks Massive ETF Accumulation In IVV, SPY, QQQ ↗

Which S&P500 stocks are moving on Monday? ↗

February 23, 2026

Via Chartmill

February 23, 2026

Hedge funds bet heavily on big tech, Eli Lilly, and others in Q4, driving flows into SPY, QQQ, as mega-cap stocks dominated portfolio allocations.

Via Benzinga

Topics ETFs

Novo Nordisk's Loss Is Eli Lilly's Gain ↗

February 23, 2026

Eli Lilly shares climb after Novo Nordisk trial miss. CagriSema trails tirzepatide in 84-week weight-loss study results.

Via Benzinga

Is Microsoft Down? Downdetector Reports Issues With Azure, Outlook, MSFT 365 ↗

February 23, 2026

Microsoft flagged that services that require Multi-Factor Authentication may return gateway timeout errors for users in the U.S.

Via Stocktwits

Why Eli Lilly Stock Just Popped ↗

February 23, 2026

Eli Lilly has some good news for investors today. Novo Nordisk has some bad news (which is also good news for Lilly).

GLP-1 weight loss drug CagriSema may not be the salvation Novo Nordisk was hoping for.

Why Novo Nordisk Stock Just Crashed ↗

February 23, 2026

Eli Lilly: The Weight‑Loss and Diabetes Powerhouse I'd Hold Through Any Market Crash ↗

February 23, 2026

The stock looks unstoppable.

High Volatility and Earnings Crossroads: A Deep Dive into Hims & Hers Health (HIMS) in 2026

Topics Artificial Intelligence Economy

February 23, 2026

As of February 23, 2026, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself at a critical crossroads that has sent shockwaves through the telehealth and pharmaceutical sectors. Once the darling of the...

Via Finterra

Topics Artificial Intelligence Intellectual Property Lawsuit

Eli Lilly Surges as Novo Nordisk’s "CagriSema" Stumbles in High-Stakes Obesity Head-to-Head

February 23, 2026

Shares of Eli Lilly (NYSE: LLY) climbed 3.5% on February 23, 2026, as the pharmaceutical giant tightened its grip on the multi-billion-dollar obesity market. The rally was fueled by disappointing...

Novo Nordisk Shares Plunge 13% as Next-Gen Weight Loss Drug CagriSema Fails to Topple Eli Lilly in Landmark Trial

February 23, 2026

COPENHAGEN — Shares of the Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) plummeted more than 13% in premarket trading on Monday, February 23, 2026, following the release of highly anticipated...

Eli Lilly Announces New Version Of Zepbound With A Month’s Worth Of Doses In KwikPen — How Much Will It Cost? ↗

Topics Earnings

Eli Lilly Unusual Options Activity For February 23 ↗

February 23, 2026

Via Benzinga

February 23, 2026

The new Zepbound KwikPen can be purchased by cash-paying customers through LillyDirect, Eli Lilly’s direct-to-customer website.

Via Stocktwits

Wondering what's happening in today's S&P500 pre-market session? ↗

February 23, 2026

Via Chartmill

Novo Nordisk Dives As Next-Gen Obesity Drug Fails To Match Eli Lilly's Zepbound ↗

February 23, 2026

Novo's next-gen drug CagriSema didn't match weight loss from Eli Lilly's Zepbound.

Via Investor's Business Daily

1 Reason I'm Seriously Considering Novo Nordisk as a Buy‑and‑Never‑Sell Obesity Stock ↗

February 23, 2026

Novo Nordisk investors get a second bite at the Ozempic apple.

Viking stock has plenty of room to run.

3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds ↗

February 23, 2026

Biopharma company Corcept Therapeutics (NASDAQ:CORT) will be announcing earnings results this Tuesday afternoon. Here’s what to expect.

Corcept (CORT) Q4 Earnings: What To Expect

February 22, 2026

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be announcing earnings results this Tuesday after market close. Here’s what you need to know.

Topics Artificial Intelligence World Trade

Jazz Pharmaceuticals Earnings: What To Look For From JAZZ

February 22, 2026

Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) will be announcing earnings results this Tuesday after market hours. Here’s what investors should know.

Topics Artificial Intelligence Government World Trade

Supernus Pharmaceuticals (SUPN) To Report Earnings Tomorrow: Here Is What To Expect

February 22, 2026

Animal health company Elanco (NYSE:ELAN) will be reporting earnings this Tuesday before market open. Here’s what you need to know.

Topics Artificial Intelligence

What To Expect From Elanco’s (ELAN) Q4 Earnings

February 22, 2026

Even a great stock has a ceiling.

Could Vertex Stock Help Turn $100,000 Into $1 Million by 2036? ↗

February 22, 2026

These two healthcare stocks are likely headed higher from their current prices.

Topics Intellectual Property

2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200 ↗

February 22, 2026